229 related articles for article (PubMed ID: 38464332)
21. Treatment of overdose in the synthetic opioid era.
Skolnick P
Pharmacol Ther; 2022 May; 233():108019. PubMed ID: 34637841
[TBL] [Abstract][Full Text] [Related]
22. Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.
Sellen K; Markowitz B; Parsons JA; Leece P; Handford C; Goso N; Hopkins S; Klaiman M; Shahin R; Milos G; Wright A; Charles M; Morrison L; Strike C; Orkin A;
BMC Public Health; 2023 May; 23(1):888. PubMed ID: 37189052
[TBL] [Abstract][Full Text] [Related]
23. Legal requirements and recommendations to prescribe naloxone.
Haffajee RL; Cherney S; Smart R
Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
[TBL] [Abstract][Full Text] [Related]
24. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
[TBL] [Abstract][Full Text] [Related]
25. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
[TBL] [Abstract][Full Text] [Related]
26. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
27. Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico.
Salvador JG; Sussman AL; Takeda MY; Katzman WG; Moya Balasch M; Katzman JG
Harm Reduct J; 2020 May; 17(1):31. PubMed ID: 32404109
[TBL] [Abstract][Full Text] [Related]
28. Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review.
Kim HK; Nelson LS
Expert Opin Drug Saf; 2015 Jul; 14(7):1137-46. PubMed ID: 25865597
[TBL] [Abstract][Full Text] [Related]
29. Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions.
Qeadan F; Madden EF
Addiction; 2022 Feb; 117(2):457-471. PubMed ID: 34286895
[TBL] [Abstract][Full Text] [Related]
30. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
[TBL] [Abstract][Full Text] [Related]
31. Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.
Adams JW; Duprey M; Khan S; Cance J; Rice DP; Bobashev G
Harm Reduct J; 2023 Oct; 20(1):150. PubMed ID: 37848945
[TBL] [Abstract][Full Text] [Related]
32. Hostility, compassion and role reversal in West Virginia's long opioid overdose emergency.
Ondocsin J; Mars SG; Howe M; Ciccarone D
Harm Reduct J; 2020 Oct; 17(1):74. PubMed ID: 33046092
[TBL] [Abstract][Full Text] [Related]
33. Pediatric opioid fatalities: What can we learn for prevention?
Bishop-Freeman SC; Young KA; Aurelius MB; Hudson JS
J Forensic Sci; 2021 Jul; 66(4):1410-1419. PubMed ID: 33893645
[TBL] [Abstract][Full Text] [Related]
34. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
Mistler CB; Chandra DK; Copenhaver MM; Wickersham JA; Shrestha R
J Community Health; 2021 Apr; 46(2):349-357. PubMed ID: 32997253
[TBL] [Abstract][Full Text] [Related]
35. "That's why we're speaking up today": exploring barriers to overdose fatality prevention in Indianapolis' Black community with semi-structured interviews.
Seo DC; Satterfield N; Alba-Lopez L; Lee SH; Crabtree C; Cochran N
Harm Reduct J; 2023 Oct; 20(1):159. PubMed ID: 37891632
[TBL] [Abstract][Full Text] [Related]
36. SAFE - Home Opioid Management Education (SAFE-HOME) in older adults: a naloxone awareness program for home health workers.
McQuade BM; Koronkowski M; Emery-Tiburcio E; Golden R; Jarrett JB
Drugs Context; 2021; 10():. PubMed ID: 34970322
[TBL] [Abstract][Full Text] [Related]
37. It's what the community demands: Results of community-based emergency opioid overdose trainings.
Febres-Cordero S; Smith DJ; Wulkan AZ; Béliveau AJ; Gish A; Zine S; Fugitt L; Giordano NA
Public Health Nurs; 2023 Jan; 40(1):44-53. PubMed ID: 36377302
[TBL] [Abstract][Full Text] [Related]
38. Opioid Use Disorders in Adolescents-Updates in Assessment and Management.
Yule AM; Lyons RM; Wilens TE
Curr Pediatr Rep; 2018 Jun; 6(2):99-106. PubMed ID: 30895165
[TBL] [Abstract][Full Text] [Related]
39. Prescription opioid misuse and the need to promote medication safety among adolescents.
Abraham O; Thakur T; Brown R
Res Social Adm Pharm; 2019 Jul; 15(7):841-844. PubMed ID: 30655180
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
